成人接种活病毒疫苗后心肌炎和心包炎罕见
基于疫苗安全数据链1996至2007年416629名接种活病毒疫苗的成人,在接种后42天内识别出1例可能的心包炎和0例心肌炎;自我对照风险区间分析显示心肌心包炎风险未增加(IRR 0.57,95%CI 0.07至4.51),估计发生率0.24/10万,不高于背景发生率且远低于天花疫苗接种后报告的发生率。
要点
- 成人接种活病毒疫苗后42天内,心肌心包炎发生率为0.24/10万,不高于背景发生率。
- 自我对照风险区间分析显示接种后42天心肌心包炎风险未增加(IRR 0.57,95%CI 0.07至4.51)。
- 活病毒疫苗接种后心肌心包炎发生率远低于天花疫苗接种后报告的发生率。
核心结论
- 成人接种活病毒疫苗后心肌心包炎的发生罕见,估计发生率为0.24/10万,不高于背景发生率且远低于天花疫苗接种后报告的发生率。
研究设计与样本
- 研究基于疫苗安全数据链(Vaccine Safety Datalink),纳入1996年至2007年间416629名接种活病毒疫苗的成人,采用自我对照风险区间分析。
主要发现
- 在接种后42天内识别出1例可能的心包炎病例和0例心肌炎病例。
- 风险区间内识别1例、对照区间内识别10例,心肌心包炎风险未增加(IRR 0.57;95%CI 0.07至4.51)。
- 估计心肌心包炎发生率为0.24/10万接种者,不高于背景发生率,且远低于天花疫苗接种后报告的发生率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reports of myocarditis and pericarditis following smallpox vaccination in adults suggested a need to assess inflammatory cardiac disease risk among adults who receive live viral vaccinations. From 1996 through 2007, among 416,629 vaccinated adults in the Vaccine Safety Datalink, we identified one probable pericarditis case and no cases of myocarditis in the 42 days following a live viral vaccination. Our self-controlled risk interval analysis found that, based on one case identified during the risk interval and 10 cases during the control interval, there is no increased risk of myopericarditis in the 42 days following vaccination (IRR, 0.57; 95% CI, 0.07, 4.51). Our study suggests that the occurrence of myopericarditis following live viral vaccination is rare with an estimated incidence of 0.24 per 100,000 vaccinated, which is not higher than the background rate and is much lower than the incidence rates reported following smallpox vaccination.
引用
- Kuntz J, Crane B, Weinmann S, et al. Myocarditis and pericarditis are rare following live viral vaccinations in adults. Vaccine. 2018. PMID: 29456017. doi:10.1016/j.vaccine.2018.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。